TCM
Tributary Capital Management’s Integra LifeSciences IART Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-293,369
| Closed | -$12.1M | – | 167 |
|
2023
Q2 | $12.1M | Sell |
293,369
-5,584
| -2% | -$230K | 1.08% | 47 |
|
2023
Q1 | $17.2M | Buy |
298,953
+11,417
| +4% | +$655K | 1.59% | 27 |
|
2022
Q4 | $16.1M | Sell |
287,536
-11,653
| -4% | -$653K | 1.61% | 22 |
|
2022
Q3 | $12.7M | Sell |
299,189
-2,844
| -0.9% | -$120K | 1.33% | 36 |
|
2022
Q2 | $16.3M | Sell |
302,033
-8,754
| -3% | -$473K | 1.62% | 20 |
|
2022
Q1 | $20M | Sell |
310,787
-74,532
| -19% | -$4.79M | 1.58% | 16 |
|
2021
Q4 | $25.8M | Sell |
385,319
-22,824
| -6% | -$1.53M | 1.95% | 3 |
|
2021
Q3 | $28M | Sell |
408,143
-6,435
| -2% | -$441K | 2.16% | 2 |
|
2021
Q2 | $28.3M | Sell |
414,578
-12,039
| -3% | -$822K | 2.15% | 4 |
|
2021
Q1 | $29.5M | Sell |
426,617
-111,205
| -21% | -$7.68M | 2.3% | 2 |
|
2020
Q4 | $34.9M | Buy |
537,822
+23,517
| +5% | +$1.53M | 2.5% | 1 |
|
2020
Q3 | $24.3M | Sell |
514,305
-28,036
| -5% | -$1.32M | 2.1% | 6 |
|
2020
Q2 | $25.5M | Buy |
542,341
+37,265
| +7% | +$1.75M | 2.18% | 5 |
|
2020
Q1 | $22.6M | Buy |
505,076
+28,584
| +6% | +$1.28M | 2.3% | 4 |
|
2019
Q4 | $27.8M | Sell |
476,492
-14,112
| -3% | -$822K | 1.94% | 9 |
|
2019
Q3 | $29.5M | Sell |
490,604
-17,825
| -4% | -$1.07M | 2.14% | 5 |
|
2019
Q2 | $28.4M | Sell |
508,429
-409
| -0.1% | -$22.8K | 2% | 7 |
|
2019
Q1 | $28.4M | Buy |
508,838
+119,592
| +31% | +$6.66M | 2.06% | 5 |
|
2018
Q4 | $17.6M | Buy |
389,246
+43
| +0% | +$1.94K | 1.61% | 17 |
|
2018
Q3 | $25.6M | Buy |
389,203
+326
| +0.1% | +$21.5K | 1.94% | 7 |
|
2018
Q2 | $25M | Buy |
388,877
+613
| +0.2% | +$39.5K | 1.96% | 4 |
|
2018
Q1 | $21.5M | Buy |
388,264
+26,469
| +7% | +$1.46M | 1.8% | 8 |
|
2017
Q4 | $17.3M | Sell |
361,795
-9,484
| -3% | -$454K | 1.51% | 21 |
|
2017
Q3 | $18.7M | Sell |
371,279
-1,046
| -0.3% | -$52.8K | 1.61% | 17 |
|
2017
Q2 | $20.3M | Sell |
372,325
-36,635
| -9% | -$2M | 1.79% | 6 |
|
2017
Q1 | $17.2M | Buy |
408,960
+244,483
| +149% | +$10.3M | 1.68% | 12 |
|
2016
Q4 | $14.1M | Buy |
164,477
+11,403
| +7% | +$978K | 1.66% | 10 |
|
2016
Q3 | $12.6M | Buy |
153,074
+10,451
| +7% | +$863K | 1.64% | 3 |
|
2016
Q2 | $11.4M | Buy |
142,623
+14,962
| +12% | +$1.19M | 1.66% | 3 |
|
2016
Q1 | $8.6M | Buy |
127,661
+4,959
| +4% | +$334K | 1.36% | 10 |
|
2015
Q4 | $8.32M | Sell |
122,702
-2,136
| -2% | -$145K | 1.38% | 7 |
|
2015
Q3 | $7.43M | Buy |
124,838
+21,203
| +20% | +$1.26M | 1.24% | 17 |
|
2015
Q2 | $6.98M | Buy |
103,635
+2,417
| +2% | +$163K | 1.09% | 17 |
|
2015
Q1 | $6.24M | Buy |
101,218
+6,790
| +7% | +$419K | 0.98% | 29 |
|
2014
Q4 | $5.12M | Buy |
+94,428
| New | +$5.12M | 0.87% | 41 |
|